The SCLC-inflammatory subtype is characterized by low expression of transcription factors, such as POU2F3, NEUROD1, and ASCL1, alongside high expression of genes associated with interferon-γ activation, human leukocyte antigen, and immune checkpoints, as well as increased immune cell infiltration. This evidence concerns the gene POU2F3 and small cell lung carcinoma.